Ultima-IGF-1 LR3 0.1mg Ultima Peptides

£95.00

IGF-1 LR3 peptide research reagent is a synthetic analogue featuring enhanced bioavailability for in-vitro laboratory investigations. Ultima Peptides manufacture with analytical verification.

 

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Ultima-IGF-1 LR3 0.1mg Ultima Peptides
Ultima-IGF-1 LR3 0.1mg Ultima Peptides
£95.00

[wpforms id=”1190″ title=”true” description=”Request a call back”]

IGF-1 LR3 Peptide Research Overview

IGF-1 LR3 is a synthetic long-acting analogue of insulin-like growth factor-1, engineered with amino acid substitutions that extend its half-life compared to native IGF-1. This research peptide features modifications at position 3 (Glu to Arg) and an N-terminal extension, resulting in reduced binding to IGF binding proteins. Researchers examining cellular growth pathways and metabolic signalling often investigate this compound in controlled laboratory environments. Stroid UK Shop maintains strict quality protocols for peptide synthesis verification. The compound demonstrates stability advantages over native IGF-1, making it valuable for extended experimental protocols. Studies examine its interaction with IGF-1 receptors and downstream signalling cascades including PI3K/Akt pathways in cell culture systems.

Laboratory Research Applications

Scientific investigations utilise IGF-1 LR3 to study cellular proliferation mechanisms, muscle tissue development models, and metabolic regulation pathways. Researchers analyse its effects on protein synthesis, glucose metabolism, and cellular differentiation in controlled experimental conditions. The peptide serves as a valuable tool for investigating growth factor signalling in various tissue types. IGF-1 peptide research encompasses studies on anabolic signalling pathways and cellular energy metabolism. Comparative studies often examine differences between native IGF-1 and this modified analogue across multiple cell lines. Research investigators may incorporate IGF-1 LR3 into broader studies examining growth factor interactions. Academic laboratories utilise this compound to evaluate receptor binding affinities and downstream molecular cascades in tissue culture applications.

Product Specifications

IGF-1 LR3 Technical Data
Parameter Specification
Product Name Ultima-IGF-1 LR3
Peptide Content 0.1mg per vial
Manufacturer Ultima Peptides
Purity Grade Research Grade
Storage Temperature -20°C (lyophilised)
Reconstitution Sterile water or saline
Molecular Weight Approximately 9.1 kDa
Amino Acid Length 83 residues

Each vial contains precisely measured peptide content suitable for laboratory research protocols. Peptide research compounds require appropriate storage conditions to maintain structural integrity throughout experimental timeframes.

Research Compliance Statement

This IGF-1 LR3 peptide is manufactured exclusively for in-vitro laboratory research applications and is not intended for human consumption, clinical trials, or therapeutic use. Researchers must comply with institutional guidelines and appropriate safety protocols when handling research peptides. All experimental work should be conducted in qualified laboratory facilities with proper containment and waste disposal procedures. This product is restricted to licensed research institutions and qualified scientific personnel only.

Related